Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
National Institutes of Health · National Institute of Allergy and Infectious Diseases · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
776
total citations
- FWCI
- 43.20
- Percentile
- 100%
- References
- 33
Citations per year
Authors
19- KDKatrin D. Mayer-BarberCorresponding
National Institutes of Health, National Institute of Allergy and Infectious Diseases
- BBBruno B. Andrade
National Institute of Allergy and Infectious Diseases, National Institutes of Health
- SDSandra D. Oland
National Institutes of Health, National Institute of Allergy and Infectious Diseases
- EPEduardo P. Amaral
Universidade de São Paulo
- DLDaniel L. Barber
National Institutes of Health, National Institute of Allergy and Infectious Diseases
Topics & keywords
Topics
Keywords
- Tuberculosis
- Immunology
- Mycobacterium tuberculosis
- Medicine
- Exacerbation
- Interferon
- Disease
- Immunotherapy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.